Resources for Innovators - A Supplier Expo and Pitch Event (Boston, MA)

Vetter is a leading contract development and manufacturing organization (CDMO) that specializes in the aseptic filling of drug product into syringes, cartridges and vials. The company has extensive experience with biologics and other complex compounds, including monoclonal antibodies, peptides, interferons and vaccines. Collaborating with the top 25 pharma/biotech clients worldwide and a growing list of emerging companies, Vetter supports products from preclinical development through global market supply. Through its U.S. and European facilities, Vetter Development Service provides state-of-the-art support for early-stage products, with seamless transfer at Phase III to Vetter Commercial Manufacturing for large-scale production. The company offers state-of-the-art technology and innovative processes to promote product quality and maximize API yield. 

Vetter’s facility in Chicago, IL is dedicated to and designed for the manufacturing of GMP drug product in vials and syringes for early stage clinical trials.The Chicago facility supports preclinical through Phase II products, with seamless transfer at Phase III for large-scale manufacture at Vetter’s commercial facilities. The site complies with US and EU cGMP regulations and manufactures drug product material for multinational clinical trials.

Launched in 2011, the site employs innovative and state-of-the-art technologies, including:

• a single-use technology platform in which all product-contact materials are disposable
• short tubing lengths to minimize API loss when minimal drug substance is available
• in-line weight checks to maximize batch yield
• a fully automated vial-filling line for early-stage, high-value products
• on-site microbiology and chemical analysis labs for compendial testing and client method transfers
• co-development in vial and syringe presentations to shorten time-to-market
• ability to process batches <1L with no minimum batch size